Our focus

Our mission is to deliver medicines and solutions for a healthier every day.

Areas of focus

Our three key areas

By addressing health conditions that are unique to women, affect her disproportionately or impact her differently, we are igniting our purpose to advance the complete health of women at all stages of her life journey.

With our global portfolio in women’s health, biosimilars, and established brands, we work to provide medicines and other products to help address a wide array of conditions and diseases.

Women’s health

We are fearless in our aim to deliver innovation, improve access, and expand choice to help address therapeutic gaps in women’s health.

Women’s health plays a major role for us – because while women are the key to a healthier world, their very own health concerns have too often been ignored so far. We want to change that.

Good medical care for women must be specific to the needs of women. As experts, we want to help fill knowledge gaps; as researchers, we want to provide tailor-made therapies; and as partners, we want to advocate for women’s health at all levels of society.

Our global portfolio and innovation pipeline are focused on these key areas:

  • Bacterial vaginosis (BV)
  • Breast cancer
  • Contraception
  • Endometriosis
  • Fertility
  • Hysterectomy
  • Menopause
  • Osteoporosis
  • Polycystic ovarian syndrom (PCOS)
  • Postpartum haemorrhage (PPH)

Biosimilars

We aim to improve healthcare economies and treatment access by providing high-quality biosimilar medicines to health care systems, providers, and patients.

With insights from our customers, we work to understand the needs of all stakeholders and seek to exceed their expectations.

Helping navigate the complexities of biosimilar adoption is at the core of our commitment to enable the many potential benefits of biosimilars across the health care system. As the biosimilar landscape changes, we adapt-while maintaining an unwavering commitment to patients and providers.

We believe that ethics, empathy, and commitment will ultimately best serve all our stakeholders on the path toward value-driven change.

Established brands

Expanding upon the legacy of these products, we are applying a renewed focus on this portfolio and seizing new opportunities to bring these important treatments to people who need them.

Our portfolio embodies early innovation and deep heritage and includes medicines that have been helping patients, in some cases for decades.

Our established brands include well-known products across a range of therapeutic areas worldwide, including:

  • Cardiovascular disease (CVD)
  • Respiratory conditions
  • Dermatology
  • Central nervous system (CNS) disorders, including migraine
  • Bone health
  • Immunology
  • Non-opioid pain management

GB-NON-110573 | March 2025